Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

[Malignant transformation of multiple isolated hepatocellular adenomas. Therapeutic implications of immunohistochemical and radiological findings].

Baulieux J, Manichon AF, Bancel B, D'Errico E, Raspado O, Ducerf C, Mabrut JY, Rode A.

Bull Acad Natl Med. 2012 Feb;196(2):459-81; discussion 482-3. French.

PMID:
23420963
2.

Malignant transformation of hepatic adenomas.

Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M.

Mod Pathol. 2008 Apr;21(4):491-7. doi: 10.1038/modpathol.2008.8. Epub 2008 Feb 1.

3.

Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.

Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, Leteurtre E, Paradis V, Michalak S, Wendum D, Chiche L, Fabre M, Mellottee L, Laurent C, Partensky C, Castaing D, Zafrani ES, Laurent-Puig P, Balabaud C, Bioulac-Sage P.

Hepatology. 2006 Mar;43(3):515-24.

PMID:
16496320
4.

Genetics and imaging of hepatocellular adenomas: 2011 update.

Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR.

Radiographics. 2011 Oct;31(6):1529-43. doi: 10.1148/rg.316115527. Review.

PMID:
21997980
5.

Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.

Shafizadeh N, Genrich G, Ferrell L, Kakar S.

Hum Pathol. 2014 May;45(5):976-83. doi: 10.1016/j.humpath.2013.12.011. Epub 2014 Jan 8.

PMID:
24746201
6.

Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.

Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, Rullier A, Cubel G, Couchy G, Imbeaud S, Balabaud C, Zucman-Rossi J.

Hepatology. 2007 Sep;46(3):740-8.

PMID:
17663417
7.

Hepatocellular adenomatosis: what should the term stand for!

Frulio N, Chiche L, Bioulac-Sage P, Balabaud C.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):132-6. doi: 10.1016/j.clinre.2013.08.004. Epub 2013 Oct 11. Review.

PMID:
24126236
8.

Unexpected discovery of 2 cases of hepatocyte nuclear factor 1alpha-mutated infracentimetic adenomatosis.

Laumonier H, Rullier A, Saric J, Balabaud C, Bioulac-Sage P.

World J Gastroenterol. 2008 Aug 14;14(30):4830-3.

9.

Genetic mutation in hepatic adenoma: seeing is believing.

Chen PJ.

J Hepatol. 2006 Dec;45(6):767-9. Epub 2006 Sep 25. No abstract available.

PMID:
17034896
10.

Hepatocellular carcinoma arising in a telangiectatic hepatocellular adenoma.

González-Lara MF, Córdova-Ramón JC, Gamboa-Domínguez A, Cosme-Labarthe J, Carrillo-Pérez DL.

Ann Hepatol. 2013 Jul-Aug;12(4):626-8.

11.

New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma.

Sakellariou S, Morgan Y, Heaton N, Portmann B, Quaglia A, Tobal K.

Eur J Gastroenterol Hepatol. 2011 Jul;23(7):623-7. doi: 10.1097/MEG.0b013e328347964d.

PMID:
21566527
12.

Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis.

Calderaro J, Nault JC, Balabaud C, Couchy G, Saint-Paul MC, Azoulay D, Mehdaoui D, Luciani A, Zafrani ES, Bioulac-Sage P, Zucman-Rossi J.

Mod Pathol. 2016 Jan;29(1):43-50. doi: 10.1038/modpathol.2015.119. Epub 2015 Oct 30.

13.

Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.

Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H.

Hepatology. 2008 Sep;48(3):808-18. doi: 10.1002/hep.22417. Erratum in: Hepatology. 2008 Oct;48(4):1356.

PMID:
18688875
14.

Subtype classification of hepatocellular adenoma.

Bioulac-Sage P, Balabaud C, Zucman-Rossi J.

Dig Surg. 2010;27(1):39-45. doi: 10.1159/000268406. Epub 2010 Apr 1.

15.

Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.

Margolskee E, Bao F, de Gonzalez AK, Moreira RK, Lagana S, Sireci AN, Sepulveda AR, Remotti H, Lefkowitch JH, Salomao M.

Diagn Pathol. 2016 Mar 9;11:27. doi: 10.1186/s13000-016-0475-5.

16.

Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics.

Dhingra S, Fiel MI.

Arch Pathol Lab Med. 2014 Aug;138(8):1090-7. doi: 10.5858/arpa.2013-0183-RA. Review.

PMID:
25076298
17.

Pigmented hepatocellular adenomas have a high risk of atypia and malignancy.

Mounajjed T, Yasir S, Aleff PA, Torbenson MS.

Mod Pathol. 2015 Sep;28(9):1265-74. doi: 10.1038/modpathol.2015.83. Epub 2015 Jul 24.

18.

Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.

Hechtman JF, Raoufi M, Fiel MI, Taouli B, Facciuto M, Schiano TD, Blouin AG, Thung SN.

Am J Surg Pathol. 2011 Jun;35(6):927-32. doi: 10.1097/PAS.0b013e318218ca3f. Review.

PMID:
21572265
19.

A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.

Larson BK, Guindi M.

Am J Clin Pathol. 2017 Jun 1;147(6):557-570. doi: 10.1093/ajcp/aqx010.

PMID:
28472207
20.

Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.

van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN.

J Hepatol. 2011 Jul;55(1):120-5. doi: 10.1016/j.jhep.2010.10.030. Epub 2010 Nov 24.

PMID:
21145863

Supplemental Content

Support Center